GCV Symposium
Skip Content

17 March 2017

Redshift receives $11m in series C round

Waters Corporation has co-led a round that took bioanalytical technology producer Redshift Bioanalytics' total funding to $35m since 2005.

Author: Robert Lavine, News Editor

Redshift Bioanalytics, a US-based developer of bioanalytical tools for the life sciences industry, has completed an $11m series C round co-led by laboratory equipment producer Waters Corporation.